Meanwhile, NAPDH includes MOX1, NOX2, and NOX4 while NOX1 has been reported to be increased in NASH patients [13], and NOX2 is increased in nonalcoholic fatty liver mouse models [14]. This evidence concerns the gene CYBB and metabolic dysfunction-associated steatohepatitis.